A colleague goes for a screening, the result shows malignant cells, and the doctor says the word: cancer. They have surgery and recover, and in the meantime they submit a claim under the critical illness element of the company's group insurance – and the insurer rejects it because the tumour was “in situ”. As a broker, I see that this is the most painful type of rejection: the person concerned really did go through the shock of the diagnosis, the treatment and the fear, while the insurer points out that under the policy conditions this is not the illness the cover is for. Behind the dispute there is no bad faith, but a set of rules that few people read before signing. This article goes through the definitional exceptions: what the policy conditions exclude, why, and what the employee and HR can do.
- Critical illness cover pays not on the word of the diagnosis but on the definition set out in the policy conditions: for cancer, what typically counts is a histologically confirmed malignant tumour that has spread into the surrounding tissue, not early, localised stages.
- Typical exceptions in Hungarian policy conditions: carcinoma in situ (Tis) and non-invasive tumours, prostate cancer with a low Gleason score or at stage T1, melanoma no more than 1 mm thick and non-melanoma skin cancers; for the heart, angina and catheter-based dilation or stenting; for the brain, transient ischaemic attack (TIA).
- The excluded stages are most often left off the list because of the chance of recovery – which is why other cover belongs on the illness side alongside the critical illness element; and before signing, employees need to read the definitions chapter, not the names of the illnesses.
It is not the word of the diagnosis but the definition that pays
Critical illness cover is fixed-sum insurance: when one of the illnesses listed in the policy conditions occurs, it pays a lump sum, as described in the article on critical illness cover. The list, however, contains definitions rather than names of illnesses: each illness has a medical definition and typically a list of exceptions as well. So the insurer does not examine whether the doctor said the word “cancer”, but whether the histology report and the specialist's opinion meet the definition in the policy conditions. One set of Hungarian critical illness conditions in force from January 2026, for example, describes a malignant tumour as follows: the uncontrolled growth and spread of certain cells, leading to the destruction of tissue and requiring surgical treatment, radiotherapy and/or chemotherapy – and the diagnosis must be confirmed by a histology result and a specialist's opinion. The special conditions of group contracts follow the same logic; the specific list and the thresholds vary by insurer, so in every case it is the wording of your own contract that decides.
The cancer exceptions: in situ, early prostate cancer, thin melanoma, skin cancer
The exceptions to the cancer definition account for the typical rejections, because it is precisely the early cases discovered through screening that fall outside. The list of exceptions in the 2026 conditions referred to shows the typical elements of Hungarian practice well:
- Carcinoma in situ and non-invasive tumours. The conditions carve out tumours that have not spread beyond the cells of origin into the surrounding tissue (classified as Tis or Ta), as well as histologically benign, premalignant and low-grade malignant lesions. “In situ” means that the abnormal cells have not yet broken through the basement membrane and have not spread into the surrounding tissue – medically it is cancer, but in insurance terms, under most policy conditions, it is not.
- Early prostate cancer. The conditions referred to exclude prostate tumours with a Gleason score not exceeding 6; some Hungarian policy conditions carve out stage T1 under the TNM classification. Both approaches aim at the same thing: slow-growing forms, which often need no treatment for years, are left out.
- Melanoma by thickness. Melanoma with a depth of invasion not exceeding 1 mm is an exception under the conditions; thicker, invasive melanoma is covered.
- Non-melanoma skin cancers. Basal cell and squamous cell skin cancers are typically left out, because they rarely metastasise and are cured by local treatment.
- Other thresholds. The conditions referred to also exclude thyroid tumours no larger than 2 cm and tumours that develop in the presence of HIV infection; other policy conditions include the early stages of chronic lymphocytic leukaemia here.
It is important to see that these are not classic exclusions – it is not a matter of the insured person having breached something or engaged in a risky activity – but the boundaries of the concept of the insured event. The difference also matters in a dispute: here you can argue with medical documents, not on legal grounds.
Heart and brain: angina, stents, TIA
For circulatory illnesses the definitions are just as precise. In the conditions referred to, a heart attack is the death of part of the heart muscle due to disease of the coronary artery supplying that area, confirmed by a combination of a clinical picture characteristic of recent heart muscle death, laboratory abnormalities and a typical ECG pattern; angina pectoris, other acute coronary syndromes, heart failure, myocarditis and pericarditis are exceptions. In other words, an episode with chest pain that requires investigation in hospital but involves no death of heart muscle is not a heart attack under the conditions. Coronary artery surgery is defined as a bypass performed by opening the chest and implanting a vascular graft – procedures performed through a blood vessel using a catheter technique, that is, balloon dilation and stent implantation, are exceptions. This catches many people by surprise, because stenting is today the most common coronary procedure. For stroke, the conditions require that the neurological dysfunction can be established by an objective neurological examination at least 3 months after the event; transient ischaemic attack (TIA), injury caused by head trauma, changes in the blood vessels of the eye and a stroke that passed without symptoms are exceptions. The symptoms of a TIA pass within hours – it is a frightening event that requires investigation, but without permanent damage it does not meet the definition.
Why is the line drawn here – and what protects you in the cases left out?
The original purpose of critical illness cover is to cushion the financial consequences of illnesses that threaten life and permanently change the way a person lives: a long absence from work, expensive treatment, a life that is being reshaped. Excluding early, localised stages with a good chance of recovery serves this purpose: if the cover paid for every abnormality found at screening, the premium would rise significantly and the benefit would become unaffordable for many companies. Some products therefore offer an intermediate solution: they pay part of the sum insured for early-stage cancer – this varies by insurer and package, and it is worth looking for it in the quotation table. The other route is service-financing health insurance, which does not look at the stage but organises and pays for the care – the difference between the two approaches is covered in the article on fixed-sum insurance and service financing. Side by side, the two can cover what neither can on its own.
Two time rules also belong here. The conditions referred to stipulate a 6-month waiting period for events not caused by an accident – according to the article on waiting periods, this is typical for group contracts too, although the length varies – and several policy conditions also prescribe a survival period: the insured person must be alive for a specified time after the diagnosis, typically a few weeks, for the critical illness element to pay – the 2026 conditions referred to instead require the insured person to be alive when the event is reported – otherwise the death benefit takes its place.
What should the employee do – and what should HR do?
If you have received a rejection, as a first step ask in writing which point of the definition and which histology finding the insurer is relying on. The dispute here is medical: if the histology report does not clearly record the stage, an additional specialist opinion or a clarification of the pathology report may be decisive. The claim report and any missing documents go through the insurer's channel, in line with the document list; if the case gets stuck or disputed, I help where I can – in interpreting the policy conditions and in formulating the questions – and after the insurer's complaints procedure, the Financial Arbitration Board (PBT) or a court can decide. For HR, the lesson lies in the launch: employee communications should not say “it pays in the event of cancer”, but that it pays for the serious illnesses defined in the policy conditions, and that employees will find the definitions in the policy conditions. Before signing, the company should ask for the complete definitions chapter with each quotation and compare them: it is not the number of illnesses but the wording of the exceptions that decides what the cover is worth. The insurer pays only for what is an insured event under your contract – for the critical illness element, it is the definitional exceptions that give this sentence its content.
Do you have a question about the critical illness definitions in your own package? Book a free 20-minute consultation →
Sources
- Alfa Vienna Insurance Group: Special conditions of the 20-item supplementary critical illness insurance (DD-SZ-251216; from 1 January 2026) – definitions and exceptions for cancer, heart attack, stroke and coronary artery surgery, waiting period
- Hungarian Civil Code (Ptk., Act V of 2013) – health insurance contract (chapter on insurance contracts)
- MNB – Financial Arbitration Board (Pénzügyi Békéltető Testület)
